Breaks Categories: Stock Spotlights

WednesdayFeb 11, 2026 2:48 pm

NetworkNewsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Bringing First-in-Class Approach to Chemo and Immunotherapy

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, is focused on enhancing established cancer therapies by targeting a fundamental biological pathway involved in tumor survival and resistance. “Rather than developing standalone treatments, LIXTE is advancing a first-in-class approach designed to increase the effectiveness of chemotherapy and immunotherapy across multiple cancer indications,” reads a recent article. “At the center of LIXTE’s strategy is protein phosphatase 2A, or PP2A, an enzyme that plays a critical role in regulating cell growth, DNA repair, and survival signaling. In many cancers, PP2A activity enables tumor cells to recover from the damage caused by treatment,…

Continue Reading

FridayFeb 06, 2026 3:49 pm

NetworkNewsBreaks – Fairchild Gold Corp. (TSX.V: FAIR) (OTCQB: FCHDF) Applies Modern Techniques to Historic Goodsprings Mining District

Disseminated on behalf of Fairchild Gold Corp. (TSX.V: FAIR) (OTCQB: FCHDF) and may include paid advertising. Fairchild Gold (TSX.V: FAIR) (OTCQB: FCHDF) was featured in a recent article that discussed its positioning in the current exploration landscape. The publication reads, “For much of mining history, districts were defined by what could be seen at surface. Shallow workings, hand-dug shafts, and narrow stopes extracted high-grade material where it outcropped, often leaving deeper mineral systems unexplored. Today, the most compelling exploration stories are not about discovering new districts, but about resolving old ones with modern tools. Fairchild is applying that approach at its flagship Nevada Titan project…

Continue Reading

FridayFeb 06, 2026 3:23 pm

NetworkNewsBreaks – Trilogy Metals Inc.’s (NYSE American: TMQ) (TSX: TMQ) Key Role in Emerging Critical Minerals Hub

Disseminated on behalf of Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) and may include paid advertising. Trilogy Metals (NYSE American: TMQ) (TSX: TMQ) was featured in a recent article that discussed its key participation in Alaska’s responsible resource development amid more attention on the Ambler Access Project – the proposed 211-mile, industrial-use-only road connecting the Dalton Highway to the Upper Kobuk Mineral Projects held by Ambler Metals (Trilogy’s 50/50 joint venture with South32). The publication reads, “With the American government focusing more on securing critical mineral supply chains and Alaska quickly establishing itself as a key location, the company is demonstrating how…

Continue Reading

FridayFeb 06, 2026 2:41 pm

NetworkNewsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Positions LB-100 to Expand Effectiveness of Standard Cancer Treatment

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, is leading efforts in addressing some of the pressing challenges in cancer treatment. “Instead of developing standalone cancer drugs, the company is adopting a different strategy aimed at enhancing the overall effectiveness of existing immunotherapy and chemotherapy regimens through a novel biological target,” reads a recent article. “LIXTE’s platform is built on its proprietary LB-100 compound, a one-of-a-kind inhibitor of Protein Phosphatase 2A (‘PP2A’). PP2A is a critical enzyme involved in various cellular processes, including cell growth regulation, DNA repair, and modulation of the immune response. Through the selective inhibition of…

Continue Reading

FridayFeb 06, 2026 1:57 pm

NetworkNewsBreaks – Soligenix Inc.’s (NASDAQ: SNGX) SGX945 Shows Promise with Immune-Modulating Approach

Soligenix (NASDAQ: SNGX) was featured in a recent article that discussed the company’s release of positive top-line results from its phase 2 clinical trial evaluating SGX945 for the treatment of aphthous ulcers associated with Behçet’s. “Behçet’s disease is a rare, chronic inflammatory condition that can cause recurrent, painful ulcers, eye inflammation and systemic complications that significantly affect quality of life. Because available treatments are limited and often inconsistent, clinical trial updates in this disease area carry particular importance. Soligenix is reporting results from a phase 2a proof of concept study evaluating its investigational therapy, SGX945 (dusquetide), for the treatment of Behçet’s…

Continue Reading

FridayFeb 06, 2026 1:09 pm

NetworkNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Bringing GPS-Free Spatial Intelligence to Military and Defense

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) is positioning its technology to support military and defense by applying advanced mathematical modeling to spatial risk assessment, an approach that aligns closely with emerging priorities outlined in recent defense and technology reports. An article highlighting the company’s strides in this area reads, “A recent Proactive Investors piece outlines SPARC AI’s core tech and explains how its mathematical approach to location assessment is particularly well suited for drones and other autonomous platforms… SPARC AI has developed a solution that enables drones to assess object location without the…

Continue Reading

ThursdayFeb 05, 2026 3:17 pm

NetworkNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Positioned Amid Reshaping of Critical Mineral Supply

Disseminated on behalf of  Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising. Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) recently reflected on its efforts to advance its rare earth element (“REE”) separation technology and strategic growth while reinforcing its mission to establish a resilient, Western-aligned supply chain in the critical minerals sector. “In 2025, we focused on advancing our business plan by leveraging unprecedented government support to take a leadership position in the important business of mid-market rare earth refining and processing,” CEO Pat Ryan was quoted as saying. “Western supply chains are currently being reshaped at…

Continue Reading

ThursdayFeb 05, 2026 1:10 pm

NetworkNewsBreaks – A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) Addressing Retail’s In-Aisle Blind Spot

A2Z Cust2Mate Solutions (NASDAQ: AZ) was featured in a recent article that discussed its work to restore visibility into shopper behavior with smart carts. The publication reads, “A2Z Cust2Mate CMO Yaniv Zukerman explains that while retailers have become highly proficient at tracking transactions, pricing and inventory, they have steadily lost visibility into how shoppers actually behave inside the store . Most existing systems capture only end results, such as what was purchased and when, leaving the entire in-aisle journey largely invisible. This disconnect, he argues, creates a growing gap between how well retailers believe they understand their customers and how little they truly know about the decisions, hesitations and trade-offs that…

Continue Reading

ThursdayFeb 05, 2026 12:39 pm

NetworkNewsBreaks – Xeriant Inc. (XERI) Building Momentum in Advanced Materials with NEXBOARD(TM)

Xeriant (OTCQB: XERI) is a technology development company focused on discovering, developing and commercializing disruptive innovations, with advanced materials representing a core area of emphasis. “The most visible example of Xeriant’s advanced materials work is NEXBOARD(TM), a patent-pending composite panel that integrates recycled plastics, cellulose fibers and nanotechnology-enabled fire-retardant systems… Beyond individual milestones, Xeriant’s work in advanced materials reflects a broader strategy of applying nanotechnology to solve real-world performance challenges,” reads a recent article. “Across construction, infrastructure, industrial manufacturing and public safety, demand is rising for materials that can deliver greater durability, fire resistance and sustainability without sacrificing performance or cost…

Continue Reading

FridayJan 30, 2026 3:23 pm

NetworkNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Marks Major Progress Toward Commercial Ramp-Up

Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising. Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) is signaling a major leap forward in establishing a secure Western supply chain for heavy rare earth elements, with plans ramping up for commercial operations targeted in Louisiana in 2026. “The company recently released detailed information about significant progress on its proprietary rapid-separation technology and its transition from demonstration testing in Canada toward full deployment at a U.S. facility that could help reduce longstanding dependencies on foreign processors,” reads a recent article. “The announcement underscores not only technological advancement…

Continue Reading